Fund: GLOGBE
| Global X Genomics & Biotechnology Ucits ETF EUR | |
| IE00BM8R0N95 | |
| 02-11-2021 | |
| Equity | |
| Equity Sectors - Health Care | |
| Global X Funds | |
| Global X Management Company LLC | |
| EUR | |
| 100 | |
| 5% |
| 1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Výkonnosť fondu | -12.37% | -10.18% | 5.81% | -17.43% | -16.48% | - | - | - | - | N/A | |
| Priemerná výkonnosť (36 meraní) | - | - | - | - | - | ||||||
| Volatilita od priemernej výkonnosti | - | - | - | - | - |
| Long | Short | Net | |
|---|---|---|---|
| Stock | 99.99% | 99.99% | |
| Bond | |||
| Other | |||
| Cash | 0.01% | 0.01% |
| Aktíva | 70 mil. |
| Počet akcíí | 41 |
| Počet dlhopisov | 0 |
| Priebež. popl. | 0.50 |
| z toho Mng. popl. | 0.50 |
| Výk. prémia | |
| Trans. popl. |
| Dividenda | |
| Dividendový výnos | |
| Rozhodný dátum | |
| Frekvencia výplaty |
| Giant | 0.00% |
| Large | 6.38% |
| Medium | 40.53% |
| Small | 25.11% |
| Micro | 25.13% |
| P/E | 35.84% |
| P/BV | 3.15% |
| Healthcare | 99.99% |
| Derivatives | 0.01 |
| Výnos do splatnosti p.a. | |
| Modifikovaná durácia |
| United States | 90.53% |
| Canada | |
| Latin America | |
| United Kingdom | |
| Eurozone | 3.51% |
| Europe - ex Euro | 5.41% |
| Europe - Emerging | |
| Africa | |
| Middle East | |
| Japan | 0.54% |
| Australasia | |
| Asia - Developed | |
| Asia - Emerging | |
| Emerging Market | |
| Developed Country | 99.99% |
| Not Classified |
| Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
|---|---|---|---|---|---|
| Natera Inc | Healthcare | 7.87% | CRISPR Therapeutics AG | Healthcare | 5.41% |
| Ultragenyx Pharmaceutical Inc | Healthcare | 5.05% | Agilent Technologies Inc | Healthcare | 4.63% |
| Moderna Inc | Healthcare | 4.52% | Sarepta Therapeutics Inc | Healthcare | 3.9% |
| Illumina Inc | Healthcare | 3.77% | Bio-Techne Corp | Healthcare | 3.68% |
| Qiagen NV | Healthcare | 3.62% | Beam Therapeutics Inc | Healthcare | 3.56% |